Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study.

Autor: Ajmani AK; Dr. B. L. Kapur Super Speciality Hospital, New Delhi, India., Agrawal A; Lady Hardinge Medical College & Smt. Sucheta Kriplani Hospital, New Delhi, India., Prasad BLN; Rajiv Gandhi Institute of Medical Sciences and RIMS Government General Hospital, Srikakulam, India., Basu I; Popular Hospital, Varanasi, India., Shembalkar J; Getwell Hospital and Research Institute, Nagpur, India., Manikanth N; Government Medical College, Kerala, India., Subrahmanyam KAV; Andhra Medical College, King George Hospital, Vishakhapatnam, India., Srinivasa M; Krishna Rajendra Hospital, Mysore Medical College & Research Institute, Mysore, India., Chawla M; BSES Municipal General Hospital, Mumbai, India., Srivastava MK; Om Surgical Center & Maternity Home, Varanasi, India., Jebasingh F; Christian Medical College, Vellore, India., Achappa B; Kasturba Medical College, Mangalore, India., Agrawal RP; SP Medical College and PBM Hospital, Bikaner, India., Pulichikkat RK; Sree Narayana Institute of Medical Sciences, Kochi, India., Meena R; S.R. Kalla Memorial Gastro and General Hospital, Jaipur, India., Bhatia S; Medipoint Hospitals Pvt Ltd, Pune, India., Gupta SK; KRM Hospital and Research Centre, Lucknow, India., Dange A; Lifepoint Multispecialty Hospital, Pune, India., Srivastava A; Alkem Laboratories Ltd, Mumbai, India., Trailokya A; Alkem Laboratories Ltd, Mumbai, India. Electronic address: publication@alkem.com., Shahavi V; Alkem Laboratories Ltd, Mumbai, India., Shende S; Alkem Laboratories Ltd, Mumbai, India.

Publikováno v: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2019 Nov; Vol. 157, pp. 107860. Date of Electronic Publication: 2019 Sep 14.